Compound sixty has a really superior affinity to MDM2 (Ki < 1 nM), powerful cellular action, and a very good oral pharmacokinetic profile. Compound 60 is capable of acquiring full and very long-Long lasting tumor regression in vivo and is also currently in stage I medical trials for cancer treatment https://knoxmtyhj.onzeblog.com/32002709/not-known-factual-statements-about-ribavirin